ARCHIVES

PI Defends NCI’s National Lung Screening Trial As “Rigorous” Randomized Trial.

This article is from The Cancer Letter archive.

Vol. 32 No. 39 | November 3, 2006

Download PDF Visit The Full Archive

Related Articles

GAO Report Refutes Charges Against Control Program

May 30, 1980

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

DCPC Advisors Request New Study Section In Prevention And Control Of Chronic Disease

July 30, 1993

NIH Selects 16 Clinical Centers for Women’s Health Initiative

April 9, 1993

Samuel Broder Plans To Leave Celera.

September 10, 2010

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007